Kullathorn Thephamongkhol

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Locally Advanced

Left Ventricular

Lipopolysaccharide Induced

Neoadjuvant Chemotherapy

Top Venues

JCO global oncology

Breast cancer (Tokyo, Japan)

This page only lists publications with an associated author ORCID identifier.

Publications

Jiraporn Setakornnukul, Janjira Petsuksiri, Panid Chaysiri, Pongwut Danchaivijitr, Nuttapong Ngamphaiboon, Kullathorn Thephamongkhol
Development and Internal Validation of a Prediction Model for Nasopharyngeal Carcinoma: Using BMI and Inflammatory Response for Deciding Sequence of Chemotherapy. JCO global oncology 10 (2024)
Jiraporn Setakornnukul, Janjira Petsuksiri, Panid Chaysiri, Pongwut Danchaivijitr, Nuttapong Ngamphaiboon, Kullathorn Thephamongkhol
Development and Internal Validation of a Prediction Model for Nasopharyngeal Carcinoma: Using BMI and Inflammatory Response for Deciding Sequence of Chemotherapy. JCO global oncology 10 (2024)
Tanun Jitwatcharakomol, Jiraporn Setakornnukul, Suebwong Chuthatisith, Adune Ratanawichitrasin, Janjira Petsuksiri, Naponwan Sirima, Kullathorn Thephamongkhol
Non-irradiated area of intraoperative radiotherapy with electron technique: outcomes and pattern of failure in early-stage breast cancer from a single-center, registry study. Breast cancer (Tokyo, Japan) (2024)
Jiraporn Setakornnukul, Janjira Petsuksiri, Panid Chaysiri, Pongwut Danchaivijitr, Nuttapong Ngamphaiboon, Kullathorn Thephamongkhol
Development and Internal Validation of a Prediction Model for Nasopharyngeal Carcinoma: Using BMI and Inflammatory Response for Deciding Sequence of Chemotherapy. JCO global oncology 10 (2024)
Jiraporn Setakornnukul, Waipoj Chanvimalueng, Jayanton Patumanond, Kullathorn Thephamongkhol
Cutoff point of neutrophil-to-lymphocyte ratio for predicting survival in nasopharyngeal carcinoma. Medicine 100 (34) (2021)
Jiraporn Setakornnukul, Kullathorn Thephamongkhol
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma. BMC cancer 18 (1) (2018)